(Inclusive of all taxes)
Zortemib 2 mg Injection is an anticancer medicine. It is used to treat multiple myeloma (a type of cancer of the bone marrow) and also used to treat mantle cell lymphoma (fast-growing cancer that begins in the cells of the immune system). This Zortemib 2 mg blocks the function of some types of protein present in the cancer cell, which eventually destroys it.
This medicine may cause some adverse effects including general weakness, tiredness, nausea, vomiting, diarrhoea, constipation, loss of appetite, stomach pain, headache, pain, redness, bruising, bleeding, or hardness at the injection site, difficulty falling asleep or staying asleep. These side effects usually disappear shortly after the injection. However, if they persist or bother you, you should inform your doctor or nurse.
Before taking Zortemib 2 mg Injection, you should inform your doctor of any pre-existing medical conditions, such as low or high blood pressure, heart disease, liver disease or diabetes, peripheral neuropathy, and high cholesterol levels in the blood. You should also inform the doctor you are currently taking any other medications, including prescription drugs, over-the-counter medicines, vitamins, and herbal remedies. This is because Zortemib 2 mg may interact with other medications and result in adverse effects. It is advised during the treatment regularly monitoring blood pressure.
This medicine is unsafe for pregnant women and breastfeeding women. It may cause severe reactions in the mother that could affect the baby's health. Please take advice from your doctor. The doctor will check your health and run a few tests before starting the treatment. Zortemib 2 mg Injection is given into the vein by your doctor or nurse in a hospital or clinical setting. The dose will depend on your clinical condition, your doctor will decide how many doses to prescribe to you the improve your condition.
Multiple Myeloma (plasma cell myeloma): Zortemib 2 mg Injection is used to treat multiple myeloma a type of cancer that affects plasma cells, which are a type of white blood cell that produce antibodies. In multiple myeloma, abnormal plasma cells accumulate in the bone marrow and interfere with the production of normal blood cells. Symptoms of multiple myeloma can include bone pain, weakness and fatigue, recurrent infections, anaemia, and kidney damage.
Mantle cell lymphoma: Zortemib 2 mg Injection is used to treat Mantle cell lymphoma is a rare and aggressive form of non-Hodgkin lymphoma, which is a type of cancer that affects the lymphatic system. It typically arises from B cells, a type of white blood cell that produces antibodies to fight infection. Symptoms of mantle cell lymphoma can include enlarged lymph nodes, fatigue, weight loss, fever, night sweats, and abdominal discomfort.
Zortemib 2 mg Injection contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells. Zortemib 2 mg is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in 18 years or older patients. It may be used alone or together with other medicines.
Like all medications, Zortemib 2 mg Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Zortemib 2 mg is administered intravenously or subcutenously at a hospital or clinic setting by a doctor or nurse. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depends on what you are taking it for. You might be prescribed certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.
This medicine belongs to a class of drugs known as proteasome inhibitors. Zortemib 2 mg Injection works by blocking the action of proteasomes, which are enzyme complexes that break down proteins within cells. Proteasomes play an important role in cell growth and division, as well as the destruction of abnormal or damaged proteins. By inhibiting proteasomes, Zortemib 2 mg causes an accumulation of proteins within cancer cells, leading to their death.
Zortemib 2 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Zortemib 2 mg and report any unusual symptoms or changes in kidney function to their doctor. Your doctor may need to be adjusted the dose in such kidney disease patients.
Zortemib 2 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Zortemib 2 mg and report any unusual symptoms or changes in liver function to their doctor. Your doctor may need to be adjusted the dose in such liver disease patients.
Zortemib 2 mg Injection will not affect your ability to drive or operate machinery. In case you experience any side effects while taking Zortemib 2 mg such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
It is unknown whether Zortemib 2 mg is excreted in human milk. If you are breastfeeding and taking this medicine. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for your and your baby's health.
Animal reproduction studies have not been conducted with Zortemib 2 mg Injection.Zortemib 2 mg Injection generally consider unsafe during pregnancy. If you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Zortemib 2 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
Consumption of alcohol is not recommended while using Zortemib 2 mg Injection. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you before consuming alcohol, you can talk with a doctor or pharmacist, and they will tell you consumption of alcohol is safe or not.
1. Bortezomib, MedlinePlus, Avaliable Form
2. Mezomib 2 Mg Injection (bortezomib 2 Mg), Mba Pharmaceuticals Pvt Ltd, Avaliable Form
3. Bortezomib (velcade™) In The Treatment Of Multiple Myeloma, National Library Of Medicine, Avaliable Form